CCConstança Coelho

Constança Coelho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Constança Coelho has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Cox Regression in Survival Analysis: Practical Insights for Clinicians

    by António Gomes, Bruna Costa, Vitor Nunes, Constança Coelho

    Survival analysis is a fundamental tool in clinical research for evaluating time-to-event outcomes. While the Kaplan-Meier method remains a widely used univariable approach for estimating survival probabilities and comparing groups, it does not account for multiple risk factors simultaneously. To address this limitation, multivariable regression models are employed, with the Cox proportional hazards model (Cox regression) being the most commonly used. This paper provides a practical guide to Cox regression for clinicians, emphasizing its application in survival analysis rather than focusing on mathematical derivations. We discuss key concepts, including hazard ratios, model assumptions, variable selection, and interpretation of results. Additionally, we explore essential methodological considerations, such as assessing proportional hazards assumptions, handling missing data, and avoiding overfitting. By offering a step-by-step approach to implementing Cox regression in clinical research, this article aims to enhance understanding and improve the quality of survival analysis in medical studies. Practical examples illustrate how to interpret Cox regression results and their relevance in clinical decision-making.


  • Top Cited Papers
    Open Access

    Kaplan-Meier Survival Analysis: Practical Insights for Clinicians

    by António Pedro Gomes, Bruna Costa, Rita Marques, Vitor Nunes, Constança Coelho

    This article aims to provide a guide that will help healthcare professionals and clinical researchers from all fields that deal with Kaplan-Meier curves. Survival analysis methods are among the most frequently used in the medical sciences and in clinical research. Overall survival, progression free survival, time to recurrence, or any other clinically relevant parameter represented by a Kaplan-Meier curve will be discussed. We will present a practical and straightforward interpretation of these curves, setting aside intricate mathematical considerations. Our focus will be on essential concepts that interface with biological sciences and medicine in order to guarantee proficiency in one of the most popular yet frequently misunderstood methods in clinical research. Being familiar with these concepts is not only essential for designing new clinical studies but also for critically assessing and interpreting published data.


  • Oct biomarkers for early prognosis in diabetic macular edema treatment with ranibizumab

    by Bernardete Pessoa, João Leite, André Ferreira, João Ramalhão, João Poças, Diana José, Constança Coelho, João Figueira, Angelina Meireles, João Melo Beirão

    Background: Diabetic macular edema is the main cause of vision loss in patients with diabetic retinopathy. In this work, we aimed to assess the role of Optical Coherence Tomography (OCT) biomarkers in patients treated with ranibizumab. Methods: A prospective study enrolling 46 eyes with DME under ranibizumab intravitreal therapy with 12 months of follow-up. The primary endpoint was to assess the association between OCT biomarkers at baseline and the type of treatment response. Results: Good responders, compared with partial/non responders, had lower number of inner nuclear layer cysts (INLc) at baseline, (26.5% vs 73.5%, p = 0.035) and presented, at 12 months of follow-up, lower percentage of disorganization of retinal inner layers (12.0% vs 88.0%, p = 0.001), lower disruption of outer plexiform layer (8.7% vs 91.3%, p < 0.001) and lower outer nuclear layer cysts (17.4% vs 82.6%, p = 0.013). At the end of follow-up, it was observed a higher frequency of inner nuclear layer cysts in patients with higher glycated haemoglobin ( p = 0.028). Conclusion: This study showed the value and importance of OCT parameters, such as absence of INLc, as a prognostic therapeutic response. A normalization of the macular anatomy with ranibizumab is more likely to happen in early complete responders. The association between INLc and higher glycated haemoglobin levels showed the importance of systemic metabolic control in systemic diabetic manifestations. Clinicaltrials.gov NCT04387604.


  • Retrospective comparison between growth and retinopathy of prematurity model versus WINROP model

    by Ana C Almeida, Teresa Sandinha, Rita Azevedo, Margarida Brízido, Melissa Figueiredo, Constança Coelho, Susana Teixeira


  • Open Access

    Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema

    by Bernardete Pessoa, João Heitor Marques, João Leite, Nisa Silva, Diana José, Constança Coelho, João Figueira, Angelina Meireles, João Nuno Melo-Beirão

    Aim: Diabetic retinopathy staging system and progression predictors are soon to be considered insufficient for ophthalmologic practice. Given the growing evidence of the role of choroidal dysfunction, our purpose was to assess choroidal vascular changes with intravitreal ranibizumab (RBZ) treatment in diabetic macular edema (DME). Methods: This was a prospective longitudinal cohort study. The study included DME eyes, grouped in vitrectomized (group 1) and non-vitrectomized (group 2) eyes, submitted to RBZ in a pro re nata regimen, with 24 weeks of follow-up. Main outcome measures such as central subfield foveal thickness (CFT), choroidal thickness (CT), and choroidal vascular index (CVI) were obtained from structural OCT, and choriocapillaris flow density (CCD) was obtained from OCT angiography and analyzed before and after treatment. Results: Thirty-one patients were included, 10 eyes in group 1 and 24 eyes in group 2. The mean number of injections was 5.18 (range 2– 6). Globally, there was an improvement in BCVA (+4.3 ETDRS letters, p=0.004) and CFT (− 84.6 μm, p< 0.001) with no changes in CT, CVI, or CCD (p> 0.05). When considering only group 2, there was a significant decrease in CT (p=0.033) and a significant increase in CCD (p=0.010) 6 months after treatment, with no differences in CVI (p=0.111). Baseline CVI was correlated with visual acuity at week 24 both globally (r=0.406, p=0.029) and in group 2 (r=0.604, p=0.004). Conclusion: In non-vitrectomized eyes, choriocapillaris blood flow improves with RBZ. Baseline CVI may correlate with visual function after RBZ. ClinicalTrials.gov NCT04387604.


  • DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity in a Portuguese cohort

    by Ana C. Almeida, Luís Miguel Borrego, Margarida Brízido, Melissa Brigham de Figueiredo, Filipa Teixeira, Constança Coelho, Susana Teixeira

    Background/Objectives To determine the efficacy of the DIGIROP model in detecting treatment-requiring retinopathy of prematurity (TR-ROP) in a Portuguese cohort. Subjects/Methods Multicentre, retrospective cohort study of all consecutive preterm infants who underwent ROP screening from April 2012 to May 2019 in two neonatal units. Gestational age (GA), birth weight (BW) and sex were inserted in the DIGIROP platform. The optimal cut-off point to achieve 100% sensitivity was calculated. Area under the receiver operating characteristic curve (AUC) was calculated. Results Of the 431 infants who underwent ROP screening, 257 were eligible for DIGIROP analysis and 174 infants were excluded for having a GA outside the range 24–30 weeks imposed by the DIGIROP algorithm. Median GA was 29 weeks (range 24–30) and BW was 1060 g (range 408–2080). Twenty-tree infants (8.9%) developed TR-ROP. The highest risk obtained for TR-ROP was 0.5404 (95% CI 0.4343–0.6616) with a median achieved risk of 0.0938 (range 0.0016–0.5404). The optimal cut-off point to achieve 100% sensitivity on TR-ROP was 0.0016. The number of infants receiving ROP examinations would have been reduced from 257 to 187 infants (−27.2%) if the model was applied. Conclusions In our cohort, of 257 infants, the optimal cut-off point to achieve 100% sensitivity for TR-ROP was 0.0016 with moderate accuracy in the AUC (0.70). The number of infants requiring screening would have decreased 27.2% if the model was applied. It is essential that algorithms continue to be tested in different populations, especially in cohorts that include both younger and older GA infants.


  • Open Access

    Predictors of Photic Phenomena with a Trifocal IOL

    by Arnaldo Espaillat, Constanca Coelho, Michael J Medrano Batista, Obniel Perez

    Aim: To assess predictive factors associated with glares and halos in patients undergoing cataract surgery with PanOptix trifocal IOL implantation. Methods: Single-center retrospective study. One hundred and forty eyes from 70 patients with cataract were bilaterally implanted with a trifocal PanOptix aspherical diffractive lens between 2017 and 2019 and followed-up for six months. All patients were evaluated for refraction, corneal topography, and aberrometry pre- and post-operatively. Patients were assessed at 1 day, 6 days, 1 and 6 months after surgery. One and six months post-operatively patients were asked to complete a satisfaction questionnaire that included photic phenomena assessment. Main outcome measures were photic phenomena at 1 and 6 months of follow-up. Predictors of photic phenomena at 1 and 6 months were also analyzed. Results: A higher corneal coma was associated with more mild halos at 6 months with no association regarding other degrees of severity. The lower the age the higher the glare or halos, the higher the lens thickness and the lower the anterior chamber depth or chord μ the less halos at 1 month. A significant proportion of patients had more none/mild compared to moderate/severe glare and halos both at 1 and 6 months post-operatively. Baseline BCVA was the only predictor of halos at 1 month and glare and halos at 6 months post-surgery. Conclusion: On multivariate regression analyses, the only predictor of photic phenomena was baseline visual acuity, suggesting that patients that have a better visual acuity before surgery are more demanding regarding visual outcomes after surgery.


  • Open Access

    Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

    by Bernardete Pessoa, Luísa Malheiro, Inês Carneiro, Sílvia Monteiro, João Coelho, Constança Coelho, João Figueira, Angelina Meireles, João Nuno Melo Beirão

    Aim: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab. Methods: Single-center retrospective comparative study of patients with DME unresponsive to intravitreal bevacizumab that was switched to ranibizumab or aflibercept. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were analysed prior to and 4 months after the switch. Ocular coherence tomography (OCT) biomarkers were also analysed. Results: Fifty-six eyes from 40 patients were included in the study, 33 eyes switched to ranibizumab and 23 to aflibercept. A significant median CFT decrease was observed in both groups (p< 0.001), with no between-group differences. BCVA gain was only significant in the ranibizumab group (p< 0.001). None of the pre-baseline or baseline parameters were associated with the response to ranibizumab or aflibercept. Conclusion: In persistent DME unresponsive to bevacizumab, both anatomical and functional improvements were observed with ranibizumab whereas aflibercept only showed an anatomical improvement. Clinicaltrials.gov NCT04018833.


  • Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis

    by Ana Rita Cruz-Machado, Santiago Rodrigues-Manica, Joana Leite Silva, Irina Alho, Constança Coelho, Joana Duarte, Cláudia Florêncio, Fernando M Pimentel-Santos, José Tavares-Costa, Elsa Vieira-Sousa

    Objectives: To assess the efficacy of biologic DMARDs (bDMARDs) in achieving Assessment of Spondyloarthritis International Society partial remission (ASAS-PR) and/or Ankylosing Spondylitis Disease Activity Score inactive disease (ASDAS-ID), as remission-like surrogates, in axial SpA (axSpA). Methods: Data from randomized controlled trials (RCTs), including long-term extensions, were included. A systematic literature review was performed using the MEDLINE database (first search May 2018, updated February 2020) and PICO criteria according to Patients—adults with radiographic or non-radiographic axSpA; Intervention—any bDMARD; Comparator—placebo and/or any different drug; Outcomes—ASAS-PR and/or ASDAS-ID as primary or secondary endpoints. Meta-analysis was performed after assessment of the homogeneity of study designs, populations and outcomes. Results: After screening 155 references, a total of 22 RCTs and 28 long-term extensions were retrieved. ASAS-PR was the dominant remission-like definition used. Concerning TNF inhibitors, 14/17 RCTs provided evidence of efficacy in reaching remission at different time points: 12, 16, 24 and 28 weeks (ASAS-PR in 16–62% of patients and ASDAS-ID in 24–40% of patients). With a limited number of studies available, IL-17A inhibitors exhibited remission rates of 15–21% for ASAS-PR and 11–16% for ASDAS-ID at week 16. A meta-analysis regarding ASAS-PR was performed considering RCTs with a similar duration (12, 16 or 24 weeks). The relative risk for achieving remission was 3.864 (95% CI 2.937, 5.085). Conclusion: bDMARDs have a clear impact in axSpA remission evaluated by ASAS-PR. Nevertheless, these data show an unmet need for improved reporting of remission-like outcomes.


  • The role of prediagnostic data in injury epidemiology in preprofessional dancers

    by João Paulo Moita, António Gomes, Luís Xarez, Constança Coelho

    Introduction Pre‐professional dance training starts at very early ages, on a highly demanding environment placing students at significant risk for injury. Injury management and prevention are a matter of concern. Given the constant interchangeability of risk factors, identifying injury patterns may prove to be equally as important. Data looking back from the time of injury through context‐specific approaches, are missing. Objectives To identify activity‐related injury patterns based on pre‐diagnostic data. Methods Prospective, non‐randomized, observational study, over a 3 years period on a full‐time pre‐professional dance school featuring both gender students aged 9 ‐ 21 years old. Non‐parametric statistics were used. Results A total of 625 dance injury records from 209 students, n=68 males, n=141 females, were analysed. Season injury risk probability was identified, proving different for each skill level (SkL). Multiple individual injuries revealed a trend towards prevalence rates in Advanced level, while Index injuries incidence become more noticeable in Entry level students. Overall incidence rates had no significant differences within SkL. Anatomical location was in line with previous research, although differences were found between gender and SkL. Most injuries occurred in classes, with Jumps standing out as the main motor action associated with injury symptoms of gradual onset mechanism. Conclusion Dance injuries happen because of dance practice. Knowing the context of injury history from the injured dancer perspective is determinant for management and prevention. Pre‐diagnostic data is an umbrella term encompassing several aspects of injury background and represents fertile ground for research. Context‐specific methodological approaches are recommended.